T. Rowe Price Associates’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.97M | Sell |
2,881,677
-122,999
| -4% | -$255K | ﹤0.01% | 1229 |
|
|
2025
Q1 | $6.61M | Buy |
3,004,676
+2,958,497
| +6,407% | +$6.51M | ﹤0.01% | 1195 |
|
|
2024
Q4 | $71K | Buy |
46,179
+8,684
| +23% | +$13.4K | ﹤0.01% | 2877 |
|
|
2024
Q3 | $75K | Hold |
37,495
| – | – | ﹤0.01% | 2871 |
|
|
2024
Q2 | $132K | Buy |
37,495
+7,573
| +25% | +$26.7K | ﹤0.01% | 2700 |
|
|
2024
Q1 | $83K | Buy |
29,922
+3,991
| +15% | +$11.1K | ﹤0.01% | 2808 |
|
|
2023
Q4 | $45K | Buy |
25,931
+5,127
| +25% | +$8.9K | ﹤0.01% | 2819 |
|
|
2023
Q3 | $22K | Sell |
20,804
-35,800
| -63% | -$37.9K | ﹤0.01% | 2844 |
|
|
2023
Q2 | $66K | Buy |
56,604
+2,047
| +4% | +$2.39K | ﹤0.01% | 2763 |
|
|
2023
Q1 | $83K | Buy |
54,557
+6,320
| +13% | +$9.62K | ﹤0.01% | 2715 |
|
|
2022
Q4 | $121K | Buy |
48,237
+2,118
| +5% | +$5.31K | ﹤0.01% | 2676 |
|
|
2022
Q3 | $195K | Buy |
46,119
+14,351
| +45% | +$60.7K | ﹤0.01% | 2552 |
|
|
2022
Q2 | $89K | Sell |
31,768
-1,460
| -4% | -$4.09K | ﹤0.01% | 2772 |
|
|
2022
Q1 | $190K | Buy |
33,228
+3,233
| +11% | +$18.5K | ﹤0.01% | 2719 |
|
|
2021
Q4 | $274K | Sell |
29,995
-23,400
| -44% | -$214K | ﹤0.01% | 2627 |
|
|
2021
Q3 | $571K | Buy |
53,395
+2,800
| +6% | +$29.9K | ﹤0.01% | 2310 |
|
|
2021
Q2 | $785K | Sell |
50,595
-6,826
| -12% | -$106K | ﹤0.01% | 2165 |
|
|
2021
Q1 | $931K | Sell |
57,421
-13,077
| -19% | -$212K | ﹤0.01% | 2087 |
|
|
2020
Q4 | $1.49M | Sell |
70,498
-1,347
| -2% | -$28.5K | ﹤0.01% | 1740 |
|
|
2020
Q3 | $1.07M | Buy |
71,845
+8,730
| +14% | +$129K | ﹤0.01% | 1766 |
|
|
2020
Q2 | $928K | Buy |
63,115
+1,271
| +2% | +$18.7K | ﹤0.01% | 1818 |
|
|
2020
Q1 | $726K | Buy |
61,844
+18,874
| +44% | +$222K | ﹤0.01% | 1831 |
|
|
2019
Q4 | $1.01M | Sell |
42,970
-17,055
| -28% | -$401K | ﹤0.01% | 1878 |
|
|
2019
Q3 | $1.11M | Buy |
60,025
+12,572
| +26% | +$232K | ﹤0.01% | 1774 |
|
|
2019
Q2 | $882K | Buy |
47,453
+322
| +0.7% | +$5.99K | ﹤0.01% | 1887 |
|
|
2019
Q1 | $1.15M | Buy |
47,131
+383
| +0.8% | +$9.36K | ﹤0.01% | 1781 |
|
|
2018
Q4 | $1.21M | Buy |
46,748
+12,725
| +37% | +$330K | ﹤0.01% | 1723 |
|
|
2018
Q3 | $1.08M | Buy |
34,023
+25,320
| +291% | +$802K | ﹤0.01% | 1858 |
|
|
2018
Q2 | $338K | Buy |
+8,703
| New | +$338K | ﹤0.01% | 2298 |
|
|
2017
Q4 | – | Sell |
-15,327
| Closed | -$248K | – | 2570 |
|
|
2017
Q3 | $248K | Buy |
15,327
+4,900
| +47% | +$79.3K | ﹤0.01% | 2319 |
|
|
2017
Q2 | $144K | Buy |
+10,427
| New | +$144K | ﹤0.01% | 2439 |
|